Brief: Medigene Raises 2018 Guidance After H1 Results
Aug 7 (Reuters) - Medigene AG MDG1k.DE :
* TOTAL H1 REVENUE INCREASED BY 12% TO EUR 5.5 MILLION
* H1 EBITDA LOSS REDUCED BY 10% TO EUR 6.2 MILLION
* H1 NET LOSS FOR PERIOD REDUCED BY 3% TO EUR 7.2 MILLION
* NOW EXPECTS TO GENERATE TOTAL 2018 REVENUE OF BETWEEN EUR
9.5 -
10.5 MILLION
* IMPROVES EBITDA GUIDANCE AND NOW EXPECTS A LOWER EBITDA
LOSS OF
EUR 18 - 20 MILLION
Source text for Eikon: ID:nPex3bbWFa
Further company coverage: MDG1k.DE
((+49 30 288 85 126;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million